Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
This open-label between-subjects fMRI study (n=38) investigated the antidepressant effects of ketamine (35mg/70kg) with regard to changes in the neural correlates of emotional processing, 24 hours after infusion, in patients with major depression (n=18) compared to baseline measures from healthy volunteers (n=20). They found that ketamine rapidly increases brain responses to positive emotion, which correlated with increased connectivity of the right caudate during and improvement in depression severity.
Authors
- Sanjay Mathew
- James Murrough
- Dennis Charney
Published
Abstract
Introduction
The glutamate N-methyl-D-aspartate receptor antagonist ketamine has demonstrated antidepressant effects in individuals with treatment-resistant major depressive disorder (TRD) within 24 h of a single dose.
Methods
The current study utilized functional magnetic resonance imaging (fMRI) and two separate emotion perception tasks to examine the neural effects of ketamine in patients with TRD. One task used happy and neutral facial expressions; the other used sad and neutral facial expressions. Twenty patients with TRD free of concomitant antidepressant medication underwent fMRI at baseline and 24 h following administration of a single intravenous dose of ketamine (0.5 mg kg−1). Adequate data were available for 18 patients for each task. Twenty age- and sex-matched healthy volunteers were scanned at one time point for baseline comparison. Whole-brain, voxel-wise analyses were conducted controlling for a family-wise error rate (FWE) of P<0.05.
Results
Compared with healthy volunteers, TRD patients showed reduced neural responses to positive faces within the right caudate. Following ketamine, neural responses to positive faces were selectively increased within a similar region of right caudate. Connectivity analyses showed that greater connectivity of the right caudate during positive emotion perception was associated with improvement in depression severity following ketamine. No main effect of group was observed for the sad faces task.
Discussion
Our results indicate that ketamine specifically enhances neural responses to positive emotion within the right caudate in depressed individuals in a pattern that appears to reverse baseline deficits and that connectivity of this region may be important for the antidepressant effects of ketamine.
Research Summary of 'Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder'
Introduction
Major depressive disorder (MDD) causes substantial disability and current treatments are often inadequate, particularly for people with treatment-resistant depression (TRD). Recent research has shown that the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine can produce rapid antidepressant effects within 24 h of a single administration, motivating investigation of glutamatergic mechanisms and the neurocircuitry that ketamine may regulate. Depression is associated with biased processing of social and emotional information, characterised by increased attention to negative stimuli and blunted responses to positive stimuli; neuroimaging studies have repeatedly implicated increased limbic responses to negative stimuli and reduced prefrontal–striatal responses to positive or reward-related stimuli in MDD. Murrough and colleagues set out to examine how a single ketamine infusion alters neural responses to positive and negative emotional facial expressions in unmedicated individuals with TRD. Using functional magnetic resonance imaging (fMRI) and two separate emotion perception tasks (happy versus neutral faces; sad versus neutral faces), the study aimed to characterise baseline group differences between TRD patients and healthy volunteers and to test whether ketamine rapidly normalises dysfunctional neural activation. The investigators further tested whether neural activation or task-related functional connectivity related to clinical improvement, measured as percent change in depression severity 24 h after ketamine.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Murrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., Wong, E., Tang, C. Y., Charney, D. S., & Iosifescu, D. V. (2015). Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Translational Psychiatry, 5(2), e509-e509. https://doi.org/10.1038/tp.2015.10
References (3)
Papers cited by this study that are also in Blossom
Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)
Murrough, J. W., Perez, A. M., Pillemer, S. et al. · Biological Psychiatry (2012)
Murrough, J. W., Iosifescu, D. V., Chang, L. C. et al. · American Journal of Psychiatry (2013)
Cited By (14)
Papers in Blossom that reference this study
Mallevays, M., Fuet, L., Danon, M. et al. · MedRvix (2026)
Rodrigues, L. S., Rossi, G. N., Guerra, L. T. L. et al. · Journal of Clinical Psychopharmacology (2024)
Kopelman, J., Keller, T. A., Panny, B. et al. · Translational Psychiatry (2023)
Meshkat, S., Cao, B., Teopiz, K. M. et al. · Journal of Affective Disorders (2023)
Price, R. B., Spotts, C., Panny, B. et al. · American Journal of Psychiatry (2022)
Zhou, Y-L., Wang, C., Lan, X-F. et al. · Frontiers in Psychiatry (2022)
Norbury, A., Rutter, S. B., Collins, A. B. et al. · Neuropsychopharmacology (2021)
Alexander, L., Jelen, L. A., Mehta, M. A. et al. · Neuroscience and Biobehavioral Reviews (2021)
Murrough, J. W., Abdallah, C. G., Mathew, S. J. · Nature Reviews Drug Discovery (2021)
Reed, L. J., Nugent, A. C., Furey, M. et al. · Biological Psychiatry (2019)
Show all 14 papersShow fewer
Ionescu, D. F., Felicione, J. M., Gosai, A. et al. · Harvard Review of Psychiatry (2018)
Reed, L. J., Nugent, A. C., Furey, M. et al. · NeuroImage (2018)
Abdallah, C. G., Averill, L. A., Collins, K. A. et al. · Neuropsychopharmacology (2016)
Schwartz, J., Murrough, J. W., Iosifescu, D. V. · Evidence-Based Mental Health (2016)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.